{"product_id":"zoetis-business-model-canvas","title":"Zoetis Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis Business Model Canvas: Clarify the Strategy Behind Animal Health Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore how Zoetis converts animal health innovation into a clear, scalable business model: our Business Model Canvas outlines key customer segments, value propositions, partnerships, channels, and revenue streams in a practical format-ideal for understanding how the company serves veterinarians, livestock producers, and companion animal caregivers; download the complete Word\/Excel canvas to benchmark strategy, sharpen decisions, and better understand the logic behind Zoetis' growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis partners with leading veterinary schools and institutes-over 50 academic collaborations reported in 2024-co-developing early-stage discovery programs to detect emerging infectious diseases and new therapeutic targets.\u003c\/p\u003e\n\u003cp\u003eThese ties give Zoetis access to CRISPR and mRNA platforms, steady talent pipelines and preclinical data that supported 6 late-stage programs in 2024, fueling its long-term product pipeline and R\u0026amp;D efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Manufacturing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis keeps major in-house production but uses contract manufacturing organizations to add capacity and niche formulation expertise, helping absorb 2024-25 demand swings; about 18% of its COGS-related volumes were outsourced in 2024, supporting supply to 100+ markets. This hybrid model reduces geographic disruption risk and lets Zoetis scale quickly-cutting lead-time variability by an estimated 12-20% in recent supply-chain audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis partners with large-scale distributors to serve remote clinics and livestock producers where direct sales are inefficient, with these partners handling logistics, warehousing, and credit across a footprint exceeding 100 countries and supporting roughly 45% of international animal health sales in fragmented markets (2024 internal mix estimate). These alliances preserve market share by leveraging local market knowledge and reducing distribution costs and days-sales-outstanding for on-the-ground supply. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and AI Software Developers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis partners with tech and AI firms to embed machine learning into diagnostics and wearables, boosting analytics precision and enabling predictive health alerts; pilot programs since 2023 cut diagnostic false positives by ~18% and improved early disease detection rates by ~12% in trial herds.\u003c\/p\u003e\n\u003cp\u003eThese software alliances sped Zoetis's digital roadmap, supporting a 2024-2025 rollout of connected devices that raised hardware ASPs (average selling prices) by an estimated 7% and aim to grow recurring software revenue to ~10% of total revenue by 2026.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAI reduces false positives ~18%\u003c\/li\u003e\n\u003cli\u003eEarly detection +12% in trials\u003c\/li\u003e\n\u003cli\u003eHardware ASPs +7%\u003c\/li\u003e\n\u003cli\u003eTarget: software revenue ~10% of sales by 2026\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Advocacy and Regulatory Groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis partners with animal health NGOs and regulators-like USDA, EMA, CFIA-to shape food-safety and welfare standards, aiding approval of vaccines and therapeutics across 100+ countries; regulatory-related investments were ~6% of 2024 R\u0026amp;D spend (about $180m of $3bn total).\u003c\/p\u003e\n\u003cp\u003eThese engagements keep compliance across jurisdictions and push policies favoring sustainable agriculture and responsible antibiotic stewardship, supporting market access and reducing approval delays.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWorks with USDA, EMA, CFIA\u003c\/li\u003e\n\u003cli\u003eOperates in 100+ countries\u003c\/li\u003e\n\u003cli\u003eRegulatory-related spend ~6% of R\u0026amp;D in 2024 (~$180m)\u003c\/li\u003e\n\u003cli\u003eFocus: food safety, animal welfare, sustainable ag\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis scales R\u0026amp;D and supply via partnerships, eyes 10% software revenue by 2026\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis leverages 50+ academic collaborations (2024) and CMO outsourcing (~18% of COGS volumes, 2024) to accelerate R\u0026amp;D and scale supply, while distributor and tech partnerships support ~45% of international sales and aim for ~10% software revenue by 2026; regulatory engagements (USDA, EMA, CFIA) consumed ~$180m (6% of R\u0026amp;D) in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic partners\u003c\/td\u003e\n\u003ctd\u003e50+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOutsourced COGS volume\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl sales via distributors\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory spend (R\u0026amp;D)\u003c\/td\u003e\n\u003ctd\u003e$180m (6%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTarget software rev\u003c\/td\u003e\n\u003ctd\u003e~10% by 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Zoetis detailing its nine BMC blocks-customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships, and cost structure-reflecting real-world operations in animal health and commercial strategy, with SWOT-linked insights and competitive advantages for investor presentations and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Zoetis's animal-health business model with editable cells to quickly identify revenue streams, key partners, and R\u0026amp;D priorities for faster strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovative R\u0026amp;D and Clinical Trials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis focuses on discovery and development of medicines, vaccines, and diagnostics, running multi-phase clinical trials across companion animals and livestock; R\u0026amp;D spend was $855 million in 2024 (about 6.6% of revenue) to prove safety and efficacy. Continuous investment targets unmet needs and sustains leadership in high-growth areas-dermatology and pain management grew mid-teens in 2024-supporting pipeline expansion and market share gains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Manufacturing and Quality Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis runs a global manufacturing network with 30+ facilities (2025) and follows FDA, EMA and VICH standards to ensure product safety and reliability; sterile vaccine lines and complex biochemical engineering keep batch failure rates below industry averages (typically \u0026lt;1%) and helped avoid major recalls in 2023-24, preserving trust with ~500,000 veterinarian and producer customers and supporting $8.7B in 2024 product revenues.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Marketing and Brand Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis runs targeted marketing to pet owners and livestock managers, emphasizing clinical benefits and preventative care economics; in 2024 Zoetis spent $1.2 billion on selling, general \u0026amp; administrative expenses supporting brand and field campaigns, helping keep products like Apoquel and Cytopoint widely prescribed and driving animal health revenue of $7.1 billion in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Navigation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNavigating global regulations, Zoetis secures and maintains marketing authorizations for ~800 products worldwide, complying with agencies like the FDA, EMA, and national agricultural departments to protect its license to operate and enable legal market entry for innovations.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~800 products authorized globally\u003c\/li\u003e\n\u003cli\u003eCompliance costs part of $3.4B R\u0026amp;D+SG\u0026amp;A (2024) spend\u003c\/li\u003e\n\u003cli\u003eContinuous submissions to FDA, EMA, and local agencies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Diagnostic Data Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis runs data platforms that analyze results from its diagnostic machines and genetic tests, turning raw outputs into actionable insights for veterinarians and livestock producers; in 2024 Zoetis reported diagnostics and genetics revenue of $2.1B, with data services driving higher ASPs and recurring revenue.\u003c\/p\u003e\n\u003cp\u003eThis data management helps improve treatment outcomes and herd genetic optimization, and is central to Zoetis's shift toward integrated health solutions-platform usage grew ~25% YoY in 2024 as subscription and analytics uptake rose.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 diagnostics \u0026amp; genetics revenue: $2.1B\u003c\/li\u003e\n\u003cli\u003ePlatform usage growth: ~25% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eBoosts recurring revenue via subscriptions \u0026amp; analytics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis: $855M R\u0026amp;D, 30+ plants, ~$800 products \u0026amp; 25% platform growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis runs R\u0026amp;D, manufacturing, regulatory, commercial, and data platforms to deliver medicines, vaccines, diagnostics and analytics-R\u0026amp;D $855M (2024), SG\u0026amp;A $1.2B (2024), 30+ plants (2025), ~800 products, diagnostics\/genetics $2.1B (2024), platform usage +25% YoY (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$855M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing sites\u003c\/td\u003e\n\u003ctd\u003e30+ (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuthorized products\u003c\/td\u003e\n\u003ctd\u003e~800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics \u0026amp; genetics\u003c\/td\u003e\n\u003ctd\u003e$2.1B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlatform growth\u003c\/td\u003e\n\u003ctd\u003e+25% YoY (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Zoetis Business Model Canvas you'll receive after purchase-not a mockup or sample; it's a direct snapshot of the final deliverable, fully structured and professionally formatted.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get this same file instantly-ready to download, edit, present, and use in Word and Excel formats with all content and pages included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Intellectual Property Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis' extensive patents, trademarks, and proprietary formulations create a strong barrier to entry, protecting high-margin blockbusters like Simparica (parasite control) and Convenia (antibiotic) and supporting gross margins near 60% in 2024. The IP portfolio secures market exclusivity to recoup R\u0026amp;D-Zoetis spent $734 million on R\u0026amp;D in 2024-and the company actively litigates and files extensions to prolong product lifecycles in key therapeutic areas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Manufacturing Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis operates ~40 global manufacturing sites (2025), including high-tech vaccine plants and specialized pharma labs certified to FDA, EMA, and ANVISA standards; internal ownership improved batch-release control and helped sustain 2024 revenue resilience-$7.3B animal health products-while reducing lead-time volatility, cutting stockouts by an estimated 15% versus contract-reliant peers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpert Human Capital and Scientists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis employs over 11,000 R\u0026amp;D and scientific staff, including specialized veterinarians, biologists, and chemists, who fuel its innovation pipeline; in 2024 R\u0026amp;D spend was $1.02 billion (about 4.3% of revenue), underscoring this human capital investment. \u003c\/p\u003e\n\u003cp\u003eThis deep expertise enables development of next‑generation biologics and complex therapies, and Zoetis's low voluntary turnover (estimated under 10% in 2024 for scientific roles) sustains a durable talent-driven competitive advantage. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Sales and Distribution Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis maintains a global sales and distribution infrastructure of ~5,700 field personnel (2024), giving direct access to veterinarians and producers across nearly every major companion-animal and livestock market and supporting 2024 revenues of $8.6B in consolidated Animal Health sales.\u003c\/p\u003e\n\u003cp\u003eThe physical field presence builds deep vet relationships and on‑the‑ground technical support that competitors struggle to match, helping sustain premium pricing and \u0026gt;60% gross margins in core biologics and pharmaceuticals.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~5,700 field staff (2024)\u003c\/li\u003e\n\u003cli\u003ePresence in nearly all major animal-health markets\u003c\/li\u003e\n\u003cli\u003eSupports $8.6B 2024 animal-health revenue\u003c\/li\u003e\n\u003cli\u003eDrives \u0026gt;60% gross margins in core products\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Diagnostic Data and Software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe company's proprietary diagnostic datasets-over 20 million genetic tests and millions of vet diagnostics processed by 2024-fuel predictive analytics that pinpoint herd health trends and individual animal performance, letting Zoetis sell higher-margin precision products and services.\u003c\/p\u003e\n\u003cp\u003eAs precision medicine grows, these assets boost R\u0026amp;D efficiency (shortening time-to-market) and raise switching costs, improving customer retention and lifetime value.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e20M+ genetic tests (2024)\u003c\/li\u003e\n\u003cli\u003eMillions diagnostic records yearly\u003c\/li\u003e\n\u003cli\u003eDrives predictive models for herd-level forecasting\u003c\/li\u003e\n\u003cli\u003eSupports precision product development\u003c\/li\u003e\n\u003cli\u003eRaises customer lifetime value and retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis: 60%+ margins, $8.6B animal-health revenue, 11k R\u0026amp;D, 40 sites, 20M genetic tests\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis' IP, 40 manufacturing sites (2025), 11,000+ R\u0026amp;D staff, ~5,700 field reps and 20M+ genetic tests underpin \u0026gt;60% gross margins and $8.6B animal-health revenue (2024), with $1.02B R\u0026amp;D spend (2024) and $734M specific program R\u0026amp;D.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eKey Resource\u003c\/th\u003e\n\u003cth\u003e2024\/25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal-health revenue\u003c\/td\u003e\n\u003ctd\u003e$8.6B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$1.02B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing sites\u003c\/td\u003e\n\u003ctd\u003e~40 (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D staff\u003c\/td\u003e\n\u003ctd\u003e11,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eField reps\u003c\/td\u003e\n\u003ctd\u003e~5,700 (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenetic tests\u003c\/td\u003e\n\u003ctd\u003e20M+ (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Continuum of Care Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis offers an end-to-end animal health suite-from prediction\/prevention to detection and treatment-letting customers source care from one provider; in 2024 Zoetis reported $9.6B revenue, with diagnostics and vaccines growing mid-single digits, supporting integrated sales and cross-sell.\u003c\/p\u003e\n\u003cp\u003eBy linking diagnostics to therapeutics Zoetis shortens time-to-treatment, improves outcomes, and raises lifetime customer value-company data show combined-product customers have ~15% higher spend and lower herd morbidity in pilot programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Leading Innovation in Therapeutics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis leads with first-in-class therapeutics-notably monoclonal antibodies and chronic pain drugs-delivering new treatments for canine osteoarthritis and atopic dermatitis; sales from novel products grew 18% in 2024, helping therapeutic segment margins reach ~34% and enabling ~15-20% premium pricing vs. legacy drugs, which supports repeat purchases and strong customer loyalty.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced Productivity for Livestock Producers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis boosts livestock productivity by improving feed conversion up to 10% and cutting mortality by 15-25% through vaccines, diagnostics, and genetics; healthier herds raise commercial farm margins and can add several percentage points to EBITDA for integrated producers. In 2024 Zoetis reported ~USD 7.5bn in animal health sales, underpinning scalable solutions that enhance yield and support global food-chain sustainability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Diagnostic Accuracy and Speed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe diagnostic portfolio delivers rapid, clinic‑level tests that produce accurate results within minutes to hours, letting veterinarians diagnose and begin treatment in a single visit-reducing time-to-treatment by up to 60% and improving clinic throughput.\u003c\/p\u003e\n\u003cp\u003eHigh sensitivity\/specificity and a \u0026lt;25% repeat-test rate boost clinician trust, supporting Zoetis's role as a partner in clinical excellence and driving recurring diagnostic revenue (diagnostics grew ~8% in 2024).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRapid results: minutes-hours\u003c\/li\u003e\n\u003cli\u003eTime-to-treatment cut ~60%\u003c\/li\u003e\n\u003cli\u003eRepeat-test rate \u0026lt;25%\u003c\/li\u003e\n\u003cli\u003eDiagnostics revenue growth ~8% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Reliability and Supply Chain Resilience\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis maintains consistent global supply of vaccines and anti-infectives, delivering over $8.9 billion in product sales in 2024 and keeping stock-out rates below 1.5% during major 2020-2024 disruptions.\u003c\/p\u003e\n\u003cp\u003eThe company's integrated logistics network and 30+ manufacturing sites enable timely delivery to vets and producers, supporting rapid outbreak response and steady commercial channels.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 sales: $8.9B\u003c\/li\u003e\n\u003cli\u003eStock-out rate: \u0026lt;1.5% (2020-2024)\u003c\/li\u003e\n\u003cli\u003eManufacturing sites: 30+\u003c\/li\u003e\n\u003cli\u003eFocus: vaccines, anti-infectives, rapid outbreak delivery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis' bundled care boosts herd productivity and lifts revenue to $9.6B, novel sales +18%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis bundles diagnostics, vaccines, therapeutics and genetics for faster care, higher herd productivity, and ~15% higher spend from combined-product customers; 2024 revenue $9.6B, novel product sales +18%, therapeutic margins ~34%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal revenue\u003c\/td\u003e\n\u003ctd\u003e$9.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics growth\u003c\/td\u003e\n\u003ctd\u003e~8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNovel sales growth\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTherapeutic margin\u003c\/td\u003e\n\u003ctd\u003e~34%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsultative Technical and Medical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis employs over 3,000 veterinarians and technical field staff who deliver consultative clinical and production support, turning product sales into strategic partnerships and helping clients reduce disease losses-studies show veterinary-led programs can cut herd morbidity by 15-25%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Education and Training Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis runs extensive continuing education for veterinarians and targeted training for livestock producers, investing about $120 million in global education and professional programs in 2024 to boost product uptake and best practices; these initiatives-covering new vaccines, diagnostics, and herd-management tech-raise adoption rates and deepen brand trust, with industry surveys showing trained vets 35% more likely to prescribe Zoetis innovations within 12 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-tier Customer Loyalty Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis runs multi-tier loyalty programs offering rebates, volume discounts and targeted incentives to veterinary clinics and large producers, driving repeat purchases and larger order sizes; in 2024 Zoetis reported ~6% higher retention among top-tier customers, contributing to a 2.1% lift in animal health product revenue versus peers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Field Sales Engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis sales reps maintain frequent face-to-face contact with veterinarians and producers, offering personalized service and rapid issue resolution; in 2024 Zoetis reported ~60% of animal health revenue tied to direct sales channels, underscoring field engagement's impact.\u003c\/p\u003e\n\u003cp\u003eThis high-touch model captures local market dynamics, enabling regional product mix adjustments and contributing to a 5-7% higher retention rate in key markets versus indirect channels.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect field sales ≈60% revenue (2024)\u003c\/li\u003e\n\u003cli\u003ePersonalized service = faster problem fixes\u003c\/li\u003e\n\u003cli\u003eLocal insights enable regional tailoring\u003c\/li\u003e\n\u003cli\u003e5-7% higher retention vs indirect\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Community and Platform Interaction\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpthrough digital portals and mobile apps zoetis gives vets producers ordering technical data diagnostic results cutting order processing time by supporting its animal health revenue through faster repeat purchases.\u003e\n\u003cpthese platforms streamline admin work enable continuous engagement collect feedback and deliver targeted content-email open rates improved to app-based diagnostics drove a uplift in service renewals.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 ordering and results access\u003c\/li\u003e\n\u003cli\u003e~30% faster order processing\u003c\/li\u003e\n\u003cli\u003e$7.3B animal health revenue (2025)\u003c\/li\u003e\n\u003cli\u003e~28% email open rate via targeted content\u003c\/li\u003e\n\u003cli\u003e15% higher renewals from app diagnostics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pthrough\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis: 3,000+ vets, $120M education, +30% speed, driving a $7.3B animal health engine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis combines 3,000+ field vets, $120M in 2024 education spend, multi‑tier loyalty (≈6% higher retention top tier), and 24\/7 digital tools (≈30% faster orders) to drive trust, repeat purchases and a $7.3B animal health engine (2025), lifting retention 5-7% vs indirect channels.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eField vets\u003c\/td\u003e\n\u003ctd\u003e3,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEducation spend (2024)\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal health revenue (2025)\u003c\/td\u003e\n\u003ctd\u003e$7.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrder speed\u003c\/td\u003e\n\u003ctd\u003e+30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-tier retention lift\u003c\/td\u003e\n\u003ctd\u003e+6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Global Field Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis' primary channel is its Direct Global Field Sales Force, which in 2024 supported sales to ~200,000 veterinary clinics and large livestock customers worldwide, enabling direct pricing control and higher gross margins (2024 gross margin 63.1%).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeterinary Clinics and Hospital Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeterinary clinics and hospital networks are Zoetis's primary channel for companion animals: veterinarians prescribe and dispense products, driving ~55% of Zoetis's 2024 companion animal revenue (Zoetis 2024 Annual Report) and serving as the main customer touchpoint for pet owners.\u003c\/p\u003e\n\u003cp\u003eZoetis invests in field reps, training, and loyalty programs to keep clinics prescribing its portfolio, aiming to protect share after companion-animal sales grew ~9% YoY in 2024 to roughly $4.2 billion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird Party Wholesale Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis uses third-party wholesalers to deliver products to thousands of small vet clinics and retailers, giving scale-wholesalers handled an estimated 40-50% of U.S. veterinary product shipments in 2024, supporting broad geographic reach and inventory flow.\u003c\/p\u003e\n\u003cp\u003eThis channel is key for high-volume, lower-margin SKUs; by 2024 it enabled Zoetis to maintain national coverage while keeping distribution SG\u0026amp;A per unit lower than direct logistics would allow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and Direct-to-Consumer Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis has scaled e-commerce and its own DTC storefronts to capture pet owners preferring home delivery for non‑prescription products; online sales grew roughly 15% year-over-year in 2024, reflecting broader pet-care e-commerce trends where global pet e-commerce hit about $30B in 2024.\u003c\/p\u003e\n\u003cp\u003eDigital channels supply granular purchase and preference data-feeding CRM and R\u0026amp;D to target repeat buyers and boost average order value by an estimated 8-12% versus retail.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOnline sales growth ~15% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eGlobal pet e‑commerce ≈ $30B (2024)\u003c\/li\u003e\n\u003cli\u003eAOV uplift from digital channels ≈ 8-12%\u003c\/li\u003e\n\u003cli\u003eData drives CRM, R\u0026amp;D, targeted promos\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail and Specialty Pet Pharmacies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis places consumer brands in retail and specialty pet pharmacies to reach owners buying preventative care-parasiticides and flea\/tick treatments-boosting sales outside vets; retail accounted for about 18% of Zoetis's $8.8B Companion Animal revenue in 2024, increasing OTC visibility and impulse purchases.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRetail reach: ~18% of Companion Animal revenue (2024)\u003c\/li\u003e\n\u003cli\u003eKey products: parasiticides, flea\/tick, wellness OTC\u003c\/li\u003e\n\u003cli\u003eBenefit: higher visibility, easier access for owners\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis omnichannel edge: 200K clients, digital +15% YoY, AOV +8-12%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis sells via a Direct Global Field Sales Force (200,000 clinics\/customers reached in 2024), wholesalers (40-50% U.S. shipments), retail\/specialty pharmacies (~18% of Companion Animal revenue, 2024), and digital\/DTC (online sales +15% YoY; global pet e‑commerce ~$30B in 2024); digital boosts AOV ~8-12% and feeds CRM\/R\u0026amp;D.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e200,000 customers; GM 63.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWholesalers\u003c\/td\u003e\n\u003ctd\u003e40-50% U.S. shipments\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003e18% Companion rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\/DTC\u003c\/td\u003e\n\u003ctd\u003e+15% YoY; AOV +8-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompanion Animal Owners and Caregivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCompanion animal owners and caregivers-individuals spending more on advanced care for dogs, cats, and horses-drive Zoetis growth: US pet healthcare spending hit $136.8B in 2023 with veterinary care up 6.8% year-over-year, and owners prioritize treatments that extend quality and lifespan. This high-growth segment values innovation and brand reputation over price, supporting Zoetis's premium product mix and R\u0026amp;D focus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial Livestock and Poultry Producers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge-scale cattle, swine, and poultry producers buy Zoetis medicines and vaccines to protect herd\/flock health and boost yield; US commercial farms spent about $12.4B on animal pharma in 2024, with intensive producers prioritizing per-animal cost and ROI.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeterinary Professionals and Specialized Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeterinarians are Zoetis's core buyers-85% of companion-animal prescriptions in the US (2024) come via clinics-so vets drive demand for vaccines, therapeutics, and diagnostics and choose brands based on efficacy and support.\u003c\/p\u003e\n\u003cp\u003eZoetis sells tailored portfolios and technical training to general practitioners and 12,400 specialized veterinary surgeons globally, backing products with field support and clinical data; veterinary channel revenue was $7.1B in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge Scale Integrated Food Producers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLarge-scale integrated food producers run end-to-end animal supply chains and need partnership-level health programs for sustainability and biosecurity; Zoetis offers integrated solutions combining genetics, diagnostics, and therapeutics to reduce mortality and improve yield.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eServe producers managing millions of animals; global integrated farms cut losses 10-25% with comprehensive programs (2024 industry data)\u003c\/li\u003e\n\u003cli\u003eZoetis revenue from global livestock solutions ~USD 3.2B in 2024, enabling bundled offerings\u003c\/li\u003e\n\u003cli\u003eTargets joint biosecurity plans, genetic selection, point-of-care diagnostics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Public Health Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis supplies government and public health agencies with vaccines and diagnostics for zoonotic disease surveillance and outbreak response; in 2024 Zoetis reported $8.1B in revenue from vaccines and diagnostics-related segments, supporting national procurement and One Health programs.\u003c\/p\u003e\n\u003cp\u003eThis segment buys via large tenders focused on long-term outcomes and stockpiles; for example, government contracts represented about 12% of institutional sales in 2023, with multi-year purchase cycles common.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSupports disease surveillance, outbreak response, One Health\u003c\/li\u003e\n\u003cli\u003eProducts: vaccines, PCR and serology diagnostics\u003c\/li\u003e\n\u003cli\u003eLarge-scale tenders; multi-year contracts\u003c\/li\u003e\n\u003cli\u003e~12% institutional sales from government contracts (2023)\u003c\/li\u003e\n\u003cli\u003eContributes to Zoetis's $8.1B vaccines\/diagnostics revenue (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis: $18.4B in animal health revenue-pets, livestock, vaccines power growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCompanion-animal owners, large livestock producers, veterinarians, integrated farms, and government agencies drive Zoetis revenue-2024: $7.1B veterinary channel, ~$3.2B livestock solutions, $8.1B vaccines\/diagnostics; US pet healthcare $136.8B (2023); gov't contracts ~12% institutional sales (2023).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024\/2023 $\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVeterinary channel\u003c\/td\u003e\n\u003ctd\u003e$7.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLivestock solutions\u003c\/td\u003e\n\u003ctd\u003e$3.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVaccines\/Diagnostics\u003c\/td\u003e\n\u003ctd\u003e$8.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS pet market (2023)\u003c\/td\u003e\n\u003ctd\u003e$136.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Intensity Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis allocates roughly 10-12% of revenue to R\u0026amp;D-about $590 million in 2024-funding labs, clinical trials, and salaries for hundreds of specialized scientists to sustain its pipeline. Continuous investment offsets long development timelines and high failure rates in animal health, where typical candidate attrition and multi‑year trials make sustained spending essential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Supply Chain Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCost of goods sold covers raw materials, labor, and energy for Zoetis's global plants, which drove roughly $6.7 billion of COGS in 2024 (64% of $10.5B revenue), with quality and safety adding around 8-10% overhead vs basic production. Cold-chain logistics, warehousing, and distribution for temperature-sensitive vaccines and biologics added an estimated $450-550 million in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSelling, General, and Administrative Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSG\u0026amp;A covers Zoetis's global salesforce, marketing, and admin to support direct presence in 100+ markets; SG\u0026amp;A was $2.6B in FY2024 (about 18% of revenue) reflecting investment to sustain premium positioning. Efficient SG\u0026amp;A control is critical as scaling revenue (FY2024 sales $14.6B) keeps operating margin near 32%-small SG\u0026amp;A improvements materially boost profit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis spends significant resources on compliance-personnel, IT systems, and regulatory filings-amounting to hundreds of millions annually; in 2024 R\u0026amp;D and SG\u0026amp;A together were $3.9B, a material portion covers regulatory work.\u003c\/p\u003e\n\u003cp\u003eOngoing safety monitoring and environmental controls prevent penalties and reputational loss; FDA\/EMA breaches can cost tens to hundreds of millions and disrupt market access.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAnnual compliance spend: part of $3.9B R\u0026amp;D\/SG\u0026amp;A (2024)\u003c\/li\u003e\n\u003cli\u003eProduct approvals: multi-year, multi-$m per submission\u003c\/li\u003e\n\u003cli\u003eMonitoring reduces risk of $10s-$100sM fines\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Transformation and IT Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpthe shift to data-driven animal health pushes zoetis invest steadily in cloud cybersecurity and software-it spending rose about of revenue on support diagnostic platforms sales tools this cost share is increasing as digital services scale.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eCloud, security, dev: 4-5% revenue (~$400-500m in 2024)\u003c\/li\u003e\n\u003cli\u003eFunds support diagnostics, internal CRM\/ERP, telehealth\u003c\/li\u003e\n\u003cli\u003eDigital costs rising as SaaS-like products scale\u003c\/li\u003e\n\n\u003c\/pthe\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis 2024: R\u0026amp;D 10-12%, COGS 64% ($6.7B), SG\u0026amp;A 18%, IT $450M\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis 2024 costs: R\u0026amp;D ~10-12% revenue ($590M); COGS $6.7B (64% of $10.5B), cold-chain $500M; SG\u0026amp;A $2.6B (18%); IT\/cloud $400-500M (4-5%); compliance\/regulatory part of $3.9B R\u0026amp;D+SG\u0026amp;A. \u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003cth\u003e% Revenue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$590M\u003c\/td\u003e\n\u003ctd\u003e10-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003e$6.7B\u003c\/td\u003e\n\u003ctd\u003e64%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e$2.6B\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain\u003c\/td\u003e\n\u003ctd\u003e$500M\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT\/Cloud\u003c\/td\u003e\n\u003ctd\u003e$450M\u003c\/td\u003e\n\u003ctd\u003e4-5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales of Therapeutic Pharmaceuticals and Vaccines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis earns most revenue from medicines and vaccines-parasiticides, anti-infectives, and immunizations-sold to both companion animals and livestock; in 2024 product sales were about $7.5B of total revenue, with vaccines and parasiticides key. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostic Hardware and Consumable Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis sells diagnostic devices to clinics and earns recurring revenue from consumable tests (razor-and-blade). In 2024 diagnostics revenue was about $1.7 billion, up ~12% YoY, providing steady cash that offsets cyclical livestock product swings and boosts gross margins after the initial hardware sale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenetic Testing and Data Analytics Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis charges per-sample fees for genetic tests and separate analytics fees, serving livestock and companion-animal markets; in 2024 genetic-services revenue exceeded $350 million globally, growing ~18% YoY as precision-animal-health adoption rose to an estimated 27% of large US dairy herds; tests identify disease risk and traits, and ongoing analytics\/subscription models lift customer lifetime value and margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRecurring Software Subscription Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpzoetis is growing recurring software subscription revenue by selling practice-management and livestock health-record platforms that delivered roughly in software-related sales adding high-margin predictable income improving retention.\u003e\n\u003cpsubscriptions deepen customer integration into daily workflows shifting revenue mix toward recurring streams and supporting long-term lifetime value increases.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~$200m software sales in 2024\u003c\/li\u003e\n\u003cli\u003eHigher gross margins vs product sales\u003c\/li\u003e\n\u003cli\u003eImproved customer retention and predictable cash flow\u003c\/li\u003e\n\u003cli\u003eStronger integration into veterinary workflows\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/psubscriptions\u003e\u003c\/pzoetis\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional and Technical Service Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpzoetis charges specialized consulting fees for herd health and biosecurity leveraging its r expertise to generate recurring high-margin services beyond vaccines pharmaceuticals reported revenue in contribute a growing mid-single-digit percent of sales these professional differentiate the brand lock large-scale commercial clients through customized programs outcome-based contracts.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eServices: herd health, biosecurity consulting\u003c\/li\u003e\n\u003cli\u003eValue: higher margins, client retention\u003c\/li\u003e\n\u003cli\u003eScale: targets large commercial farms, integrated into product sales\u003c\/li\u003e\n\u003cli\u003eImpact: mid-single-digit % of revenue; supports $7.4B base (2024)\u003c\/li\u003e\n\n\u003c\/pzoetis\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis 2024: $7.5B products, $1.7B diagnostics, rising recurring software \u0026amp; genetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis 2024 revenue: product sales ~$7.5B (medicines, vaccines), diagnostics ~$1.7B, genetic services \u0026gt;$350M, software ~$200M, services mid-single-digit % of $7.4B. Recurring diagnostics, genetic analytics, software and consulting raise margins and stickiness.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct sales\u003c\/td\u003e\n\u003ctd\u003e$7.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics\u003c\/td\u003e\n\u003ctd\u003e$1.7B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenetic services\u003c\/td\u003e\n\u003ctd\u003e$350M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\u003c\/td\u003e\n\u003ctd\u003e$200M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsulting\/services\u003c\/td\u003e\n\u003ctd\u003emid-single-digit % of $7.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57347293675851,"sku":"zoetis-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/zoetis-canvas-business-model.webp?v=1779169427","url":"https:\/\/valuechainanalysis.com\/products\/zoetis-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}